BRO Stock Declines 27.1% in a Year: What Should Investors Do Now?

Brown & Brown shares have fallen 27.1% over the past year, pressured by soft organic growth, moderating property rates, elevated operating costs and acquisition-related leverage. Q2 2026 commissions and fees rose 32.4% year over year to $1.65 billion, while Accession added about $410 million of revenue; however, interest expense surged 96.1% to $100 million and long-term debt stood at $7.76 billion. Consensus forecasts call for 2026 revenue growth of 19.2% to $7.04 billion and EPS growth of 5.6%, while the 14.12x forward P/E implies a discount to the 15.59x industry average; Zacks maintains a Hold stance.

Analysis

BRO's apparent valuation discount is not yet a clean mean-reversion setup: reported growth is acquisition-heavy while underlying organic growth sits at levels that leave little room to absorb wage inflation, amortization, and a sharply higher financing burden. The key earnings question over the next 1-3 quarters is whether acquired revenue converts into incremental EBITDA fast enough to offset the step-up in interest expense; the stated synergy target is modest relative to the acquisition revenue base and should not be capitalized aggressively before margin evidence appears.

Competitive dynamics favor scale brokers in a softening property-rate environment, but not equally. AON and AJG have broader multinational placement capabilities and may be better positioned to defend organic growth through cross-selling, whereas BRO's acquisition-led model is more exposed if agency multiples remain elevated or debt markets stay restrictive. WTW is the cleaner relative beneficiary if buyers rotate toward lower balance-sheet and integration risk rather than simply seeking the lowest headline P/E.

The near-term catalyst is a second-half organic-growth and margin inflection, not additional deal announcements or AI partnerships. A miss on Retail/Specialty organic growth, another increase in net interest expense, or a failure to show sequential integration-margin improvement would likely compress BRO's multiple further; conversely, sustained organic growth above roughly 4% with stable adjusted margin would support a rerating over 6-12 months. Consensus may be underestimating the durability of client retention, but is also likely over-crediting buybacks when leverage reduction competes directly for cash flow.

Key Decisions for Investors

• Remain neutral BRO into the next earnings print; upgrade to a 6-12 month long only if organic growth exceeds 4% and adjusted operating margin is at least stable sequentially. Target 15-20% upside from multiple normalization; exit if organic growth falls below 2% or net interest expense rises materially again.
• Express relative quality defensively over the next 1-3 months: long WTW / short BRO in equal dollar amounts. The trade captures BRO-specific integration and leverage risk while retaining insurance-broker exposure; reassess if BRO delivers two consecutive quarters of margin expansion.
• Do not treat the reported revenue growth as a catalyst for ACN despite its advisory relationship. Material AI implementation revenue, seat reductions, or measurable brokerage expense savings are missing; place ACN on an earnings-call watchlist rather than establish a position.
• Monitor property-rate renewal data and brokerage organic-growth disclosures from AON and AJG. Broad deceleration across all three would favor reducing broker exposure rather than rotating within the group, since commission yield pressure would overwhelm relative execution differences.